Trials / Completed
CompletedNCT01232348
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,643 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the safety (ADR related to beta stimulant drugs, unexpected ADRs) and efficacy of Symbicort in daily practice and the control status on bronchial asthma and Patient satisfaction
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2010-11-02
- Last updated
- 2011-12-07
Locations
47 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01232348. Inclusion in this directory is not an endorsement.